Increased vulnerability of primary neuronal cultures to rotenone and VPS35 mutations have also been reported (Tsika et al., 2014), suggesting that increased PD susceptibility due to combinatory effects between rotenone and genetic modifications is not limited to just a single gene. This evidence concerns the gene VPS35 and Parkinson disease.